Skip to main content
. 2022 Sep 30;14(19):4812. doi: 10.3390/cancers14194812

Figure 5.

Figure 5

The TGMO-based screen. Through consecutive rounds of screening (Search 1–3) and data modeling [47], the strongest and most robust drug interactions define the final drug combination selection, to converge into two final ODC1 and ODC2.